Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restasis for Ocular Rosacea
NCT00348335Phase 4Completed
- Sponsor
- Ophthalmic Consultants of Long Island
- Start
- Jun 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine 2% ophthalmic solution in ocular rosacea, sponsored by Ophthalmic Consultants of Long Island. Started Jun 2006; status: completed.
02
Drugs
cyclosporine 2% ophthalmic solution
03
Conditions
ocular rosacea
Beyond the preview
Go deeper on NCT00348335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348335.